Charitable entity of ReposiTrak (TRAK) CEO sells 7,500 shares
Rhea-AI Filing Summary
ReposiTrak, Inc. director and CEO Randall K. Fields reported pre-planned insider sales executed by a charitable entity associated with him. RK Fields Charitable 2022, LLC sold a total of 7,500 shares of ReposiTrak common stock in open-market transactions on March 16–17, 2026 at weighted average prices slightly above $8 per share.
The filing states these sales occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the related charitable trust to help meet charitable commitments. After these sales, that LLC held 77,500 shares. The Form 4 also shows Fields continues to hold 3,483,955 ReposiTrak common shares directly, plus additional indirect holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
Positive
- None.
Negative
- None.
Insights
Pre-planned charitable sales of 7,500 ReposiTrak shares look routine relative to Fields’ large remaining stake.
The Form 4 shows a charitable LLC associated with CEO Randall K. Fields sold 7,500 ReposiTrak common shares over two days at prices slightly above $8 per share. The footnotes state the transactions were executed automatically under a Rule 10b5-1 trading plan to fund charitable commitments.
This pattern is typically viewed as a weak information signal because timing is pre-set rather than discretionary. Context matters: Fields still directly owns 3,483,955 common shares, and the charitable LLC retains 77,500 shares, alongside other indirect positions. Together, these figures indicate he continues to have substantial exposure to ReposiTrak equity despite the modest net sell activity.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,428 | $8.048 | $11K |
| Sale | Common Stock | 6,072 | $8.0466 | $49K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
Footnotes (1)
- The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC. The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $8.01 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $8.00 to $8.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
